Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?-Reference-Cited by-同舟云学术

Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?

Published:2009-11 Issue:11 Volume:41 Page:2098-2108
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Arias Hugo R.

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference93 articles.

1. Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion;Alkondon;J Pharm Exp Ther,2005

2. [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter;Aloyo;J Pharmacol Exp Ther,1995

3. Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial;Anderson;Obes Res,2002

4. Dopamine transporter availability in medication free and in bupropion treated depression: A 99mTc-TRODAT-1 SPECT study;Árgyelán;J Affective Disorders,2005

5. Ligand-gated ion channel receptor superfamilies;Arias,2006

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The co-use of nicotine and prescription psychostimulants: A review of their behavioral and neuropharmacological interactions;Drug and Alcohol Dependence;2023-07

2. Determination of Bupropion and Its Impurities via a Chaotropic Chromatography Method Following Analytical Quality-by-Design Principles for Method Development;Pharmaceuticals;2022-09-28

3. Drug-Associated Parosmia: New Perspectives from the WHO Safety Database;Journal of Clinical Medicine;2022-08-09

4. AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation;Expert Opinion on Investigational Drugs;2022-07-06

5. Prevalence of depression in schizophrenia and related disorders;Cognitive and Behavioral Dysfunction in Schizophrenia;2021